Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The FDA reportedly told drugmakers that approved monoclonal antibodies to protect infants against respiratory syncytial virus ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...

FDA officials are newly scrutinizing several approved therapies to treat RSV in babies despite the fact that these shots were shown to be safe in clinical trials ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...

Vaccination of pregnant women against respiratory syncytial virus is linked to a substantial reduction in infants' risk for ...

Nearly 1,000 flu cases have been reported to the Erie County Department of Health since Oct. 1 but only seven RSV cases have ...